Hereditary angioedema:

Indications for: RUCONEST

Treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

Limitations of Use:

Efficacy not established in HAE patients with laryngeal attacks.

Adult Dosage:

Give by slow IV inj over 5 mins. <84kg: 50 IU/kg. ≥84kg: 4200 IU. Max 4200 IU/dose. May give second dose if attack symptoms persist; max 2 doses/24hrs.

Children Dosage:

Not established.

RUCONEST Contraindications:

Allergy to rabbits or rabbit-derived products.

RUCONEST Warnings/Precautions:

Discontinue if hypersensitivity reactions occur. Monitor patients with known risk factors for thrombotic events (eg, indwelling venous catheter, history of thrombosis, atherosclerosis, morbid obesity, immobility). Labor & delivery. Pregnancy (Cat.B). Nursing mothers.

RUCONEST Classification:

C1 inhibitor.

RUCONEST Interactions:

Risk of thrombotic events with concomitant oral contraceptives or certain androgens.

Adverse Reactions:

Headache, nausea, diarrhea; thrombotic events, hypersensitivity reactions (may be severe).

Generic Drug Availability:


How Supplied:

Single-use vial—1